nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyridostigmine—Lacrimation—Fluorouracil—head and neck cancer	0.0445	0.0445	CcSEcCtD
Pyridostigmine—Chest tightness—Docetaxel—head and neck cancer	0.0403	0.0403	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.0324	0.0324	CcSEcCtD
Pyridostigmine—Lacrimation—Docetaxel—head and neck cancer	0.0322	0.0322	CcSEcCtD
Pyridostigmine—Lacrimation increased—Fluorouracil—head and neck cancer	0.0284	0.0284	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Fluorouracil—head and neck cancer	0.022	0.022	CcSEcCtD
Pyridostigmine—Chest discomfort—Docetaxel—head and neck cancer	0.0214	0.0214	CcSEcCtD
Pyridostigmine—Lacrimation increased—Docetaxel—head and neck cancer	0.0205	0.0205	CcSEcCtD
Pyridostigmine—Drowsiness—Hydroxyurea—head and neck cancer	0.0204	0.0204	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Vinblastine—head and neck cancer	0.0199	0.0199	CcSEcCtD
Pyridostigmine—Lethargy—Fluorouracil—head and neck cancer	0.0194	0.0194	CcSEcCtD
Pyridostigmine—Blood pressure increased—Docetaxel—head and neck cancer	0.0189	0.0189	CcSEcCtD
Pyridostigmine—Cardiac arrest—Fluorouracil—head and neck cancer	0.0181	0.0181	CcSEcCtD
Pyridostigmine—Alopecia—Vinblastine—head and neck cancer	0.0177	0.0177	CcSEcCtD
Pyridostigmine—Dry skin—Fluorouracil—head and neck cancer	0.0174	0.0174	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Docetaxel—head and neck cancer	0.0168	0.0168	CcSEcCtD
Pyridostigmine—Alopecia—Hydroxyurea—head and neck cancer	0.0161	0.0161	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Docetaxel—head and neck cancer	0.0159	0.0159	CcSEcCtD
Pyridostigmine—Vertigo—Vinblastine—head and neck cancer	0.0157	0.0157	CcSEcCtD
Pyridostigmine—Convulsion—Vinblastine—head and neck cancer	0.0151	0.0151	CcSEcCtD
Pyridostigmine—Lethargy—Docetaxel—head and neck cancer	0.014	0.014	CcSEcCtD
Pyridostigmine—Epistaxis—Fluorouracil—head and neck cancer	0.0138	0.0138	CcSEcCtD
Pyridostigmine—Convulsion—Hydroxyurea—head and neck cancer	0.0138	0.0138	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.0131	0.0131	CcSEcCtD
Pyridostigmine—Paraesthesia—Vinblastine—head and neck cancer	0.0128	0.0128	CcSEcCtD
Pyridostigmine—Dry skin—Docetaxel—head and neck cancer	0.0126	0.0126	CcSEcCtD
Pyridostigmine—Cramp muscle—Docetaxel—head and neck cancer	0.0124	0.0124	CcSEcCtD
Pyridostigmine—Feeling abnormal—Vinblastine—head and neck cancer	0.0117	0.0117	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.0116	0.0116	CcSEcCtD
Pyridostigmine—Alopecia—Fluorouracil—head and neck cancer	0.0116	0.0116	CcSEcCtD
Pyridostigmine—Somnolence—Hydroxyurea—head and neck cancer	0.0115	0.0115	CcSEcCtD
Pyridostigmine—Abdominal pain—Vinblastine—head and neck cancer	0.0113	0.0113	CcSEcCtD
Pyridostigmine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.0107	0.0107	CcSEcCtD
Pyridostigmine—Hypersensitivity—Vinblastine—head and neck cancer	0.0105	0.0105	CcSEcCtD
Pyridostigmine—Asthenia—Vinblastine—head and neck cancer	0.0102	0.0102	CcSEcCtD
Pyridostigmine—Epistaxis—Docetaxel—head and neck cancer	0.00997	0.00997	CcSEcCtD
Pyridostigmine—Convulsion—Fluorouracil—head and neck cancer	0.00992	0.00992	CcSEcCtD
Pyridostigmine—Myalgia—Fluorouracil—head and neck cancer	0.00975	0.00975	CcSEcCtD
Pyridostigmine—Diarrhoea—Vinblastine—head and neck cancer	0.00974	0.00974	CcSEcCtD
Pyridostigmine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00957	0.00957	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Docetaxel—head and neck cancer	0.00945	0.00945	CcSEcCtD
Pyridostigmine—Confusional state—Fluorouracil—head and neck cancer	0.00942	0.00942	CcSEcCtD
Pyridostigmine—Asthenia—Hydroxyurea—head and neck cancer	0.00931	0.00931	CcSEcCtD
Pyridostigmine—Vomiting—Vinblastine—head and neck cancer	0.00905	0.00905	CcSEcCtD
Pyridostigmine—Headache—Vinblastine—head and neck cancer	0.00892	0.00892	CcSEcCtD
Pyridostigmine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00888	0.00888	CcSEcCtD
Pyridostigmine—Hypotension—Fluorouracil—head and neck cancer	0.00873	0.00873	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00851	0.00851	CcSEcCtD
Pyridostigmine—Nausea—Vinblastine—head and neck cancer	0.00846	0.00846	CcSEcCtD
Pyridostigmine—Paraesthesia—Fluorouracil—head and neck cancer	0.00839	0.00839	CcSEcCtD
Pyridostigmine—Alopecia—Docetaxel—head and neck cancer	0.00839	0.00839	CcSEcCtD
Pyridostigmine—Somnolence—Fluorouracil—head and neck cancer	0.00831	0.00831	CcSEcCtD
Pyridostigmine—Vomiting—Hydroxyurea—head and neck cancer	0.00825	0.00825	CcSEcCtD
Pyridostigmine—Rash—Hydroxyurea—head and neck cancer	0.00819	0.00819	CcSEcCtD
Pyridostigmine—Dermatitis—Hydroxyurea—head and neck cancer	0.00818	0.00818	CcSEcCtD
Pyridostigmine—Headache—Hydroxyurea—head and neck cancer	0.00813	0.00813	CcSEcCtD
Pyridostigmine—Muscle spasms—Docetaxel—head and neck cancer	0.00795	0.00795	CcSEcCtD
Pyridostigmine—Nausea—Hydroxyurea—head and neck cancer	0.00771	0.00771	CcSEcCtD
Pyridostigmine—Feeling abnormal—Fluorouracil—head and neck cancer	0.0077	0.0077	CcSEcCtD
Pyridostigmine—Urticaria—Fluorouracil—head and neck cancer	0.00742	0.00742	CcSEcCtD
Pyridostigmine—Loss of consciousness—Docetaxel—head and neck cancer	0.00726	0.00726	CcSEcCtD
Pyridostigmine—Convulsion—Docetaxel—head and neck cancer	0.00716	0.00716	CcSEcCtD
Pyridostigmine—Myalgia—Docetaxel—head and neck cancer	0.00704	0.00704	CcSEcCtD
Pyridostigmine—Hypersensitivity—Fluorouracil—head and neck cancer	0.00689	0.00689	CcSEcCtD
Pyridostigmine—Confusional state—Docetaxel—head and neck cancer	0.0068	0.0068	CcSEcCtD
Pyridostigmine—Diarrhoea—Fluorouracil—head and neck cancer	0.00639	0.00639	CcSEcCtD
Pyridostigmine—Hypotension—Docetaxel—head and neck cancer	0.0063	0.0063	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00615	0.00615	CcSEcCtD
Pyridostigmine—Paraesthesia—Docetaxel—head and neck cancer	0.00606	0.00606	CcSEcCtD
Pyridostigmine—Somnolence—Docetaxel—head and neck cancer	0.006	0.006	CcSEcCtD
Pyridostigmine—Vomiting—Fluorouracil—head and neck cancer	0.00594	0.00594	CcSEcCtD
Pyridostigmine—Rash—Fluorouracil—head and neck cancer	0.00589	0.00589	CcSEcCtD
Pyridostigmine—Dermatitis—Fluorouracil—head and neck cancer	0.00589	0.00589	CcSEcCtD
Pyridostigmine—Headache—Fluorouracil—head and neck cancer	0.00585	0.00585	CcSEcCtD
Pyridostigmine—Feeling abnormal—Docetaxel—head and neck cancer	0.00556	0.00556	CcSEcCtD
Pyridostigmine—Nausea—Fluorouracil—head and neck cancer	0.00555	0.00555	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00552	0.00552	CcSEcCtD
Pyridostigmine—Abdominal pain—Docetaxel—head and neck cancer	0.00533	0.00533	CcSEcCtD
Pyridostigmine—Hypersensitivity—Docetaxel—head and neck cancer	0.00497	0.00497	CcSEcCtD
Pyridostigmine—Asthenia—Docetaxel—head and neck cancer	0.00484	0.00484	CcSEcCtD
Pyridostigmine—Diarrhoea—Docetaxel—head and neck cancer	0.00461	0.00461	CcSEcCtD
Pyridostigmine—Vomiting—Docetaxel—head and neck cancer	0.00429	0.00429	CcSEcCtD
Pyridostigmine—Rash—Docetaxel—head and neck cancer	0.00425	0.00425	CcSEcCtD
Pyridostigmine—Dermatitis—Docetaxel—head and neck cancer	0.00425	0.00425	CcSEcCtD
Pyridostigmine—Headache—Docetaxel—head and neck cancer	0.00423	0.00423	CcSEcCtD
Pyridostigmine—Nausea—Docetaxel—head and neck cancer	0.00401	0.00401	CcSEcCtD
